Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Tam S, Yao CMK, Amit M, Gajera M, Luo X, Treistman R, Khanna A, Aashiq M, Nagarajan P, Bell D, El-Naggar A, Migden M, Wong M, Glisson B, Ferrarotto R, Esmaeli B, Rosenthal D, Li G, Weber RS, Myers JN, Gross ND.

JAMA Otolaryngol Head Neck Surg. 2019 Dec 5. doi: 10.1001/jamaoto.2019.3751. [Epub ahead of print]

PMID:
31804658
2.

The Quiet Hum: Pulmonary Arteriovenous Malformations and Hereditary Hemorrhagic Telangiectasia.

Fiore BD, Russell MC, Powers MF, Myers JN.

Am J Med. 2019 Nov 9. pii: S0002-9343(19)30945-3. doi: 10.1016/j.amjmed.2019.10.007. [Epub ahead of print] No abstract available.

PMID:
31715164
3.

Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy.

Wang L, Yang L, Han S, Zhu J, Li Y, Wang Z, Fan YH, Lin E, Zhang R, Sahoo N, Li Y, Zhang X, Wang X, Li T, Zhu XR, Zhu H, Heymach JV, Myers JN, Frank SJ.

Head Neck. 2019 Nov 11. doi: 10.1002/hed.26005. [Epub ahead of print]

PMID:
31710172
4.

Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.

Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY.

Oral Oncol. 2019 Oct;97:56-61. doi: 10.1016/j.oraloncology.2019.07.028. Epub 2019 Aug 13.

PMID:
31421472
5.

Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2019 Aug 1;25(15):4862. doi: 10.1158/1078-0432.CCR-19-2052. No abstract available.

PMID:
31371312
6.

Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma.

Oh SH, Kim WY, Kim JH, Younes MN, El-Naggar AK, Myers JN, Kies M, Cohen P, Khuri F, Hong WK, Lee HY.

Clin Cancer Res. 2019 Aug 1;25(15):4861. doi: 10.1158/1078-0432.CCR-19-2054. No abstract available.

PMID:
31371311
7.

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients.

Qian X, Nguyen DT, Dong Y, Sinikovic B, Kaufmann AM, Myers JN, Albers AE, Graviss EA.

Int J Biol Sci. 2019 May 12;15(7):1336-1344. doi: 10.7150/ijbs.33329. eCollection 2019.

8.

COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.

Lindemann A, Patel AA, Silver NL, Tang L, Liu Z, Wang L, Tanaka N, Rao X, Takahashi H, Maduka NK, Zhao M, Chen TC, Liu W, Gao M, Wang J, Frank SJ, Hittelman WN, Mills GB, Myers JN, Osman AA.

Clin Cancer Res. 2019 Sep 15;25(18):5650-5662. doi: 10.1158/1078-0432.CCR-19-0096. Epub 2019 Jul 15.

PMID:
31308060
9.

Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.

Khakhum N, Bharaj P, Myers JN, Tapia D, Walker DH, Endsley JJ, Torres AG.

PLoS Negl Trop Dis. 2019 Jul 15;13(7):e0007578. doi: 10.1371/journal.pntd.0007578. eCollection 2019 Jul.

10.

A randomized controlled trial of exercise to prevent muscle mass and functional loss in elderly hemodialysis patients: Rationale, study design, and baseline sample.

Chan KN, Chen Y, Lit Y, Massaband P, Kiratli J, Rabkin R, Myers JN.

Contemp Clin Trials Commun. 2019 Apr 19;15:100365. doi: 10.1016/j.conctc.2019.100365. eCollection 2019 Sep.

11.

Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis.

Bell AH, Prieto VG, Ferrarotto R, Goepfert RP, Myers JN, Weber R, Bell D.

Ann Diagn Pathol. 2019 Aug;41:14-23. doi: 10.1016/j.anndiagpath.2019.04.015. Epub 2019 May 5.

PMID:
31128548
12.

Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.

Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY.

J Natl Cancer Inst. 2019 May 24. pii: djz097. doi: 10.1093/jnci/djz097. [Epub ahead of print]

PMID:
31124563
13.

Ovarian fluid and its impacts on spermatozoa performance in fish: A review.

Zadmajid V, Myers JN, Sørensen SR, Ernest Butts IA.

Theriogenology. 2019 Jul 1;132:144-152. doi: 10.1016/j.theriogenology.2019.03.021. Epub 2019 Apr 3. Review.

PMID:
31022604
14.

Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma.

Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY.

Head Neck. 2019 Aug;41(8):2688-2695. doi: 10.1002/hed.25748. Epub 2019 Apr 1.

PMID:
30932264
15.

PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition.

Sambandam V, Frederick MJ, Shen L, Tong P, Rao X, Peng S, Singh R, Mazumdar T, Huang C, Li Q, Pickering CR, Myers JN, Wang J, Johnson FM.

Clin Cancer Res. 2019 Jun 1;25(11):3329-3340. doi: 10.1158/1078-0432.CCR-18-3276. Epub 2019 Feb 15.

PMID:
30770351
16.

Variations in HPV function are associated with survival in squamous cell carcinoma.

Gleber-Netto FO, Rao X, Guo T, Xi Y, Gao M, Shen L, Erikson K, Kalu NN, Ren S, Xu G, Fisch KM, Akagi K, Seiwert T, Gillison M, Frederick MJ, Johnson FM, Wang J, Myers JN, Califano J, Skinner HD, Pickering CR.

JCI Insight. 2019 Jan 10;4(1). pii: 124762. doi: 10.1172/jci.insight.124762. [Epub ahead of print]

17.

Burkholderia pseudomallei ΔtonB Δhcp1 Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection.

Khakhum N, Bharaj P, Myers JN, Tapia D, Kilgore PB, Ross BN, Walker DH, Endsley JJ, Torres AG.

mSphere. 2019 Jan 2;4(1). pii: e00570-18. doi: 10.1128/mSphere.00570-18.

18.

Proton versus photon radiation-induced cell death in head and neck cancer cells.

Wang L, Han S, Zhu J, Wang X, Li Y, Wang Z, Lin E, Wang X, Molkentine DP, Blanchard P, Yang Y, Zhang R, Sahoo N, Gillin M, Zhu XR, Zhang X, Myers JN, Frank SJ.

Head Neck. 2019 Jan;41(1):46-55. doi: 10.1002/hed.25357. Epub 2018 Dec 18.

PMID:
30561022
19.

Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.

Tanaka N, Osman AA, Takahashi Y, Lindemann A, Patel AA, Zhao M, Takahashi H, Myers JN.

Oral Oncol. 2018 Dec;87:49-57. doi: 10.1016/j.oraloncology.2018.10.018. Epub 2018 Oct 23.

20.

Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread.

Fedda F, Migden MR, Curry JL, Torres-Cabala CA, Tetzlaff MT, Aung PP, Prieto VG, Ivan D, Myers JN, Nagarajan P.

J Cutan Pathol. 2019 Feb;46(2):152-158. doi: 10.1111/cup.13388. Epub 2018 Dec 11.

PMID:
30414196
21.

Combat Readiness, Harm Aversion, and Promotion Eligibility: A Qualitative Study of U.S. Servicemembers Views on Tobacco Use and Control in the Military.

Singaraju RC, Myers JN, Owczarzak JT, Gielen AC.

Mil Med. 2019 Mar 1;184(3-4):e175-e182. doi: 10.1093/milmed/usy181.

PMID:
30085226
22.

Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.

Ma J, Fu Y, Tu YY, Liu Y, Tan YR, Ju WT, Pickering CR, Myers JN, Zhang ZY, Zhong LP.

BMC Cancer. 2018 Jul 24;18(1):758. doi: 10.1186/s12885-018-4481-8.

23.

Evaluating New Compounds to Treat Burkholderia pseudomallei Infections.

Ross BN, Myers JN, Muruato LA, Tapia D, Torres AG.

Front Cell Infect Microbiol. 2018 Jun 25;8:210. doi: 10.3389/fcimb.2018.00210. eCollection 2018.

24.

Sensory acceptable equivalent doses of β-phenylethyl isothiocyanate (PEITC) induce cell cycle arrest and retard the growth of p53 mutated oral cancer in vitro and in vivo.

Lam-Ubol A, Fitzgerald AL, Ritdej A, Phonyiam T, Zhang H, Myers JN, Huang P, Trachootham D.

Food Funct. 2018 Jul 17;9(7):3640-3656. doi: 10.1039/c8fo00865e.

PMID:
29923573
25.

Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants.

Kalu NN, Mazumdar T, Peng S, Tong P, Shen L, Wang J, Banerjee U, Myers JN, Pickering CR, Brunell D, Stephan CC, Johnson FM.

Cancer Lett. 2018 Sep 1;431:64-72. doi: 10.1016/j.canlet.2018.05.029. Epub 2018 May 25.

PMID:
29807113
26.

Outcomes of microvascular flap reconstruction of the head and neck in patients receiving systemic immunosuppressive therapy for organ transplantation.

Schaverien MV, Dean RA, Myers JN, Fang L, Largo RD, Yu P.

J Surg Oncol. 2018 Jun;117(7):1575-1583. doi: 10.1002/jso.25035. Epub 2018 May 3.

PMID:
29723399
27.

Targeting the DNA Damage Response in OSCC with TP53 Mutations.

Lindemann A, Takahashi H, Patel AA, Osman AA, Myers JN.

J Dent Res. 2018 Jun;97(6):635-644. doi: 10.1177/0022034518759068. Epub 2018 Feb 28. Review.

28.

Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay.

Abram TJ, Pickering CR, Lang AK, Bass NE, Raja R, Meena C, Alousi AM, Myers JN, McDevitt JT, Gillenwater AM, Vigneswaran N.

Transl Oncol. 2018 Apr;11(2):477-486. doi: 10.1016/j.tranon.2018.01.014. Epub 2018 Feb 24.

29.

High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma.

Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser S, Myers JN, Pickering CR.

Clin Cancer Res. 2018 Apr 1;24(7):1727-1733. doi: 10.1158/1078-0432.CCR-17-0721. Epub 2018 Jan 12.

30.

Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.

Tanaka N, Zhao M, Tang L, Patel AA, Xi Q, Van HT, Takahashi H, Osman AA, Zhang J, Wang J, Myers JN, Zhou G.

Oncogene. 2018 Mar;37(10):1279-1292. doi: 10.1038/s41388-017-0032-z. Epub 2017 Dec 22.

31.

CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition.

Gadhikar MA, Zhang J, Shen L, Rao X, Wang J, Zhao M, Kalu NN, Johnson FM, Byers LA, Heymach J, Hittelman WN, Udayakumar D, Pandita RK, Pandita TK, Pickering CR, Redwood AB, Piwnica-Worms H, Schlacher K, Frederick MJ, Myers JN.

Cancer Res. 2018 Feb 1;78(3):781-797. doi: 10.1158/0008-5472.CAN-17-2802. Epub 2017 Dec 11.

32.

Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.

Kalu NN, Mazumdar T, Peng S, Shen L, Sambandam V, Rao X, Xi Y, Li L, Qi Y, Gleber-Netto FO, Patel A, Wang J, Frederick MJ, Myers JN, Pickering CR, Johnson FM.

Oncotarget. 2017 Sep 21;8(49):86369-86383. doi: 10.18632/oncotarget.21174. eCollection 2017 Oct 17.

33.

The Next 19 Years of the American Head and Neck Society.

Myers JN.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1255-1259. doi: 10.1001/jamaoto.2017.1840. No abstract available.

PMID:
29121199
34.

Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.

Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN Jr, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR; Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium.

Cancer. 2018 Jan 1;124(1):84-94. doi: 10.1002/cncr.31063. Epub 2017 Oct 20.

35.

PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.

Wang J, Xie T, Wang B, William WN Jr, Heymach JV, El-Naggar AK, Myers JN, Caulin C.

Cancer Prev Res (Phila). 2017 Dec;10(12):684-693. doi: 10.1158/1940-6207.CAPR-17-0108. Epub 2017 Oct 10.

36.

Characterization of the Burkholderia cenocepacia TonB Mutant as a Potential Live Attenuated Vaccine.

Pradenas GA, Myers JN, Torres AG.

Vaccines (Basel). 2017 Sep 28;5(4). pii: E33. doi: 10.3390/vaccines5040033.

37.

Impact of Cardiorespiratory Fitness on Mortality in Black Male Veterans With Resistant Systemic Hypertension.

Narayan P, Doumas M, Kumar A, Faselis CJ, Myers JN, Pittaras A, Kokkinos PF.

Am J Cardiol. 2017 Nov 1;120(9):1568-1571. doi: 10.1016/j.amjcard.2017.07.055. Epub 2017 Jul 31.

PMID:
28886854
38.

APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.

Chen TW, Lee CC, Liu H, Wu CS, Pickering CR, Huang PJ, Wang J, Chang IY, Yeh YM, Chen CD, Li HP, Luo JD, Tan BC, Chan TEH, Hsueh C, Chu LJ, Chen YT, Zhang B, Yang CY, Wu CC, Hsu CW, See LC, Tang P, Yu JS, Liao WC, Chiang WF, Rodriguez H, Myers JN, Chang KP, Chang YS.

Nat Commun. 2017 Sep 6;8(1):465. doi: 10.1038/s41467-017-00493-9.

39.

Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy.

Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS.

Oral Oncol. 2017 Sep;72:90-97. doi: 10.1016/j.oraloncology.2017.07.002. Epub 2017 Jul 16.

40.

Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation.

Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, Wang J, Frederick MJ, Johnson F, Gleber-Netto FO, Fu S, Kimmel M, Wang J, Hittelman WN, Pickering CR, Myers JN, Osman AA.

Clin Cancer Res. 2017 Nov 1;23(21):6541-6554. doi: 10.1158/1078-0432.CCR-17-0947. Epub 2017 Aug 8.

41.

Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma.

Schvartsman G, Perez K, Flynn JE, Myers JN, Tawbi H.

J Immunother Cancer. 2017 Jun 20;5:45. doi: 10.1186/s40425-017-0250-5. eCollection 2017.

42.

Prehabilitation for kidney transplant candidates: Is it time?

Cheng XS, Myers JN, Chertow GM, Rabkin R, Chan KN, Chen Y, Tan JC.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13020. Epub 2017 Jul 10. Review.

PMID:
28564126
43.

Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer.

Skinner HD, Giri U, Yang LP, Kumar M, Liu Y, Story MD, Pickering CR, Byers LA, Williams MD, Wang J, Shen L, Yoo SY, Fan YH, Molkentine DP, Beadle BM, Meyn RE, Myers JN, Heymach JV.

Clin Cancer Res. 2017 Jun 1;23(11):2713-2722. doi: 10.1158/1078-0432.CCR-16-2586. Epub 2017 May 5.

44.

Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis.

Nader ME, Myers JN, Gidley PW.

J Immunother Cancer. 2017 Mar 21;5:24. doi: 10.1186/s40425-017-0226-5. eCollection 2017.

45.

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.

Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T.

Cancer Res. 2017 Mar 15;77(6):1250-1260. doi: 10.1158/0008-5472.CAN-16-2179. Review.

46.

Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.

Chang KP, Wang CI, Pickering CR, Huang Y, Tsai CN, Tsang NM, Kao HK, Cheng MH, Myers JN.

Head Neck. 2017 Jun;39(6):1131-1137. doi: 10.1002/hed.24728. Epub 2017 Feb 23.

PMID:
28230921
47.

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.

Li J, Zhao W, Akbani R, Liu W, Ju Z, Ling S, Vellano CP, Roebuck P, Yu Q, Eterovic AK, Byers LA, Davies MA, Deng W, Gopal YN, Chen G, von Euw EM, Slamon D, Conklin D, Heymach JV, Gazdar AF, Minna JD, Myers JN, Lu Y, Mills GB, Liang H.

Cancer Cell. 2017 Feb 13;31(2):225-239. doi: 10.1016/j.ccell.2017.01.005.

48.

Metabolic interrogation as a tool to optimize chemotherapeutic regimens.

Sandulache VC, Chen Y, Feng L, William WN, Skinner HD, Myers JN, Meyn RE, Li J, Mijiti A, Bankson JA, Fuller CD, Konopleva MY, Lai SY.

Oncotarget. 2017 Mar 14;8(11):18154-18165. doi: 10.18632/oncotarget.15186.

49.

Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.

Zhang M, Singh R, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Kalu NN, Pickering CR, Frederick M, Myers JN, Wang J, Johnson FM.

Cancer Lett. 2017 Apr 28;392:71-82. doi: 10.1016/j.canlet.2017.01.024. Epub 2017 Jan 23.

50.

Association Between Exercise Capacity and Late Onset of Dementia, Alzheimer Disease, and Cognitive Impairment.

Müller J, Chan K, Myers JN.

Mayo Clin Proc. 2017 Feb;92(2):211-217. doi: 10.1016/j.mayocp.2016.10.020. Epub 2017 Jan 9.

PMID:
28082018

Supplemental Content

Loading ...
Support Center